SCREENER · Screener · India NSE/BSE

India Pharma Sector Stocks 2025 — Generic Drug Export Screener NSE/BSE

Screen all NSE/BSE listed pharmaceutical companies — from Sun Pharma to mid-cap generics. Track US FDA approvals, ANDA filings, generic pricing, and R&D pipeline with SniperIQ.

Universe100+ pharma stocks NSE/BSE
Top PlayersSun Pharma, Cipla, Dr. Reddy's, Aurobindo
Key CatalystUS FDA ANDA approvals
RiskUS FDA Warning Letters, pricing pressure

Frequently Asked Questions

What drives Indian pharma stock prices?

Key drivers: US FDA ANDA approvals (entry to US generics market), domestic API pricing, INR/USD rate (US exports ~40-60% revenue), and complex/specialty drug launches. Warning letters from FDA can cause 20-40% stock drops.

Is Sun Pharma or Dr. Reddy's better?

Sun Pharma is larger with stronger domestic and US specialty presence. Dr. Reddy's is known for faster US generics execution and biosimilars. Both are high-quality. SniperIQ compares both with live AI signals and FDA pipeline data.

Track FDA Approvals and Pharma Signals on SniperIQ

SniperIQ's pharma dashboard monitors US FDA ANDA approvals, Warning Letter alerts, and AI signals for all NSE/BSE pharmaceutical stocks in real time.